NASDAQ:ORGO | Free Cash Flow | Organogenesis Holdings Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$21.13M$3.15M$17.98M
2025-12-31$39.42M$4.65M$34.77M79.56%
2025-03-31-$19.94M$3.63M-$23.56M
2024-12-31$10.94M$3.36M$7.58M98.74%
2024-03-31-$10.16M$2.22M-$12.38M
2023-12-31$10.61M$3.32M$7.29M
2023-03-31-$5.08M$7.56M-$12.64M
2022-12-31$7.8M$10.66M-$2.86M-38.15%
2022-03-31$1.41M$6.67M-$5.26M
2021-12-31$17.95M$5.23M$12.72M24.95%
2021-03-31-$1.3M$4.96M-$6.26M-62.93%
2020-12-31$23.22M$5.42M$17.8M97.17%
2020-03-31-$17.28M$4.24M-$21.53M
2019-12-31-$6.4M$3.46M-$9.86M
2019-03-31-$9.56M$317,000.00-$9.88M
2018-12-31-$17.41M$362,000.00-$17.77M
2018-03-31-$4.46M$65,000.00-$4.52M
2017-12-31-$3M
2017-03-31-$126,290.00
2016-12-31-$4.85M
2016-03-31-$241.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.31M$14.15M-$24.46M-66.05%
2024-12-31$14.21M$10.03M$4.18M485.02%
2023-12-31$30.92M$24.36M$6.55M132.52%
2022-12-31$24.86M$33.9M-$9.04M-58.20%
2021-12-31$61.98M$31.22M$30.76M32.65%
2020-12-31$5.47M$17.68M-$12.21M-70.86%
2019-12-31-$33.53M$5.98M-$39.51M
2018-12-31-$60.64M$1.86M-$62.49M
2017-12-31-$3.49M$2.43M-$5.92M
2016-12-31-$4.87M$1.36M-$6.23M